The Treatment

The biological drug TSO is a liquid suspension that is simply administered orally a few times per months.

The natural biological, and unmodified, ingredient is Trichuris suis ova (TSO).

Substantial research demonstrates that TSO stimulate the gut microbiome (microbial communities) and trigger a series of favourable immune response which reduces chronic inflammation.

Clinical Trials

ParaTech conducts state-of-the-art clinical trials to prove efficacy of the biological drug TSO. TSO have been tested in several clinical trials under EMA and FDA for several autoimmune indications (phase 1 and 2).

Overall, the clinical trials have proven that TSO has a mild safety profile and promissing effect.

In 2018, a phase 2b trial in ulcerative colitis (UC) has started.